Exogenous l-Valine Promotes Phagocytosis to Kill Multidrug-Resistant Bacterial Pathogens

Area of Science:

• Metabolic pathways
• Innate immunity
• Microbial pathogenesis

Background:

• Multidrug-resistant bacteria pose a significant global health threat.
• Antibiotic resistance necessitates alternative infection control strategies.
• Enhancing host immunity is a promising approach to combat bacterial infections.

Purpose of the Study:

• To investigate the role of host metabolites in Klebsiella pneumoniae infection.
• To identify potential therapeutic targets for bacterial infections.

Main Methods:

• Metabolomics analysis of infected mice.
• Assessing the impact of l-valine on macrophage function.
• Investigating molecular mechanisms of l-valine action.
• Evaluating combination therapy with l-valine and l-arginine.

Main Results:

• Survivors of K. pneumoniae infection showed increased l-valine levels.
• l-valine enhanced macrophage phagocytosis against K. pneumoniae and E. coli.
• l-valine activated the PI3K/Akt1 pathway and promoted nitric oxide (NO) production.
• l-arginine was essential for l-valine-mediated phagocytosis.
• Combined l-valine and l-arginine therapy demonstrated broad-spectrum efficacy against Gram-negative and Gram-positive bacteria.

Conclusions:

• Host metabolism plays a crucial role in innate immunity.
• l-valine is a key metabolite that enhances macrophage-mediated bacterial clearance.
• Metabolic modulators, like l-valine and l-arginine, offer a potential therapeutic strategy for bacterial infections.